Publications

Found 2 results
Filters: Author is W.R. Liu  [Clear All Filters]
2016
W. R. Liu, Cao, L. R., Zuo, G. J., Liu, W. R., Cao, L. R., and Zuo, G. J., Influence of chitosan nanoparticle-mediated C-erbB-2 gene silencing on invasion and apoptosis of Hep-2 cells, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. REFERENCES Chen M, Gao S, Dong M, Song J, et al (2012). Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 6: 4835-4844. http://dx.doi.org/10.1021/nn300106t Choi WJ, Kim JK, Choi SH, Park JS, et al (2004). Low toxicity of cationic lipid-based emulsion for gene transfer. Biomaterials 25: 5893-5903. http://dx.doi.org/10.1016/j.biomaterials.2004.01.031 Elbashir SM, Harborth J, Weber K, Tuschl T, et al (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213. http://dx.doi.org/10.1016/S1046-2023(02)00023-3 Hynes NE, Stern DF, et al (1994). The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198: 165-184. Janes KA, Fresneau MP, Marazuela A, Fabra A, et al (2001). Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 73: 255-267. http://dx.doi.org/10.1016/S0168-3659(01)00294-2 Jiang HL, Kim TH, Kim YK, Park IY, et al (2008). Efficient gene delivery using chitosan-polyethylenimine hybrid systems. Biomed. Mater. 3: 025013. http://dx.doi.org/10.1088/1748-6041/3/2/025013 Kandra P, Kalangi HP, et al (2015). Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges. Appl. Microbiol. Biotechnol. 99: 2055-2064. http://dx.doi.org/10.1007/s00253-015-6384-9 Lee MK, Chun SK, Choi WJ, Kim JK, et al (2005). The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26: 2147-2156. http://dx.doi.org/10.1016/j.biomaterials.2004.07.008 Luo J, Sobkiw CL, Hirshman MF, Logsdon MN, et al (2006). Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia. Cell Metab. 3: 355-366. http://dx.doi.org/10.1016/j.cmet.2006.04.003 Mahlknecht G, Maron R, Mancini M, Schechter B, et al (2013). Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth. Proc. Natl. Acad. Sci. USA 110: 8170-8175. http://dx.doi.org/10.1073/pnas.1302594110 Mooren FC, Berthold A, Domschke W, Kreuter J, et al (1998). Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. Pharm. Res. 15: 58-65. http://dx.doi.org/10.1023/A:1011996619500 Nicholson RI, Gee JM, Harper ME, et al (2001). EGFR and cancer prognosis. Eur. J. Cancer 37 (Suppl 4): S9-S15. http://dx.doi.org/10.1016/S0959-8049(01)00231-3 Semba K, Kamata N, Toyoshima K, Yamamoto T, et al (1985). A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82: 6497-6501. http://dx.doi.org/10.1073/pnas.82.19.6497 Shilpa J, Paulose CS, et al (2014). GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury. J. Mater. Sci. Mater. Med. 25: 1721-1735. http://dx.doi.org/10.1007/s10856-014-5195-3 Silva JG, Sánchez V, Polo SM, González CA, et al (2013). Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013: 4498-4501. Tzahar E, Yarden Y, et al (1998). The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim. Biophys. Acta 1377: M25-M37. Wang Q, Chen H, Zhou S, et al (2014). Typical laryngeal carcinoid tumor with recurrence and lymph node metastasis: a case report and review of the literature. Int. J. Clin. Exp. Pathol. 7: 9028-9031. Yang AQ, Wang PJ, Huang T, Zhou WL, et al (2016). Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells. Genet. Mol. Res. 15. http://dx.doi.org/10.4238/gmr.15027430 Zhao WM, Xu Y, Wang YM, Cheng ZK, et al (2007). HSV-tk gene delivered by chitosan nanoparticles killed prostate cancer cells in vitro. Tumor 27: 210-213. Zheng L, et al (2013). In vitro response of breast cancer cells (MCF-7) to albumin coated chitosan nanoparticles. China J. Modern Med. 23: 33-36.
W. R. Liu, Cao, L. R., Zuo, G. J., Liu, W. R., Cao, L. R., and Zuo, G. J., Influence of chitosan nanoparticle-mediated C-erbB-2 gene silencing on invasion and apoptosis of Hep-2 cells, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. REFERENCES Chen M, Gao S, Dong M, Song J, et al (2012). Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 6: 4835-4844. http://dx.doi.org/10.1021/nn300106t Choi WJ, Kim JK, Choi SH, Park JS, et al (2004). Low toxicity of cationic lipid-based emulsion for gene transfer. Biomaterials 25: 5893-5903. http://dx.doi.org/10.1016/j.biomaterials.2004.01.031 Elbashir SM, Harborth J, Weber K, Tuschl T, et al (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213. http://dx.doi.org/10.1016/S1046-2023(02)00023-3 Hynes NE, Stern DF, et al (1994). The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta 1198: 165-184. Janes KA, Fresneau MP, Marazuela A, Fabra A, et al (2001). Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Release 73: 255-267. http://dx.doi.org/10.1016/S0168-3659(01)00294-2 Jiang HL, Kim TH, Kim YK, Park IY, et al (2008). Efficient gene delivery using chitosan-polyethylenimine hybrid systems. Biomed. Mater. 3: 025013. http://dx.doi.org/10.1088/1748-6041/3/2/025013 Kandra P, Kalangi HP, et al (2015). Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges. Appl. Microbiol. Biotechnol. 99: 2055-2064. http://dx.doi.org/10.1007/s00253-015-6384-9 Lee MK, Chun SK, Choi WJ, Kim JK, et al (2005). The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26: 2147-2156. http://dx.doi.org/10.1016/j.biomaterials.2004.07.008 Luo J, Sobkiw CL, Hirshman MF, Logsdon MN, et al (2006). Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia. Cell Metab. 3: 355-366. http://dx.doi.org/10.1016/j.cmet.2006.04.003 Mahlknecht G, Maron R, Mancini M, Schechter B, et al (2013). Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth. Proc. Natl. Acad. Sci. USA 110: 8170-8175. http://dx.doi.org/10.1073/pnas.1302594110 Mooren FC, Berthold A, Domschke W, Kreuter J, et al (1998). Influence of chitosan microspheres on the transport of prednisolone sodium phosphate across HT-29 cell monolayers. Pharm. Res. 15: 58-65. http://dx.doi.org/10.1023/A:1011996619500 Nicholson RI, Gee JM, Harper ME, et al (2001). EGFR and cancer prognosis. Eur. J. Cancer 37 (Suppl 4): S9-S15. http://dx.doi.org/10.1016/S0959-8049(01)00231-3 Semba K, Kamata N, Toyoshima K, Yamamoto T, et al (1985). A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82: 6497-6501. http://dx.doi.org/10.1073/pnas.82.19.6497 Shilpa J, Paulose CS, et al (2014). GABA and 5-HT chitosan nanoparticles decrease striatal neuronal degeneration and motor deficits during liver injury. J. Mater. Sci. Mater. Med. 25: 1721-1735. http://dx.doi.org/10.1007/s10856-014-5195-3 Silva JG, Sánchez V, Polo SM, González CA, et al (2013). Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013: 4498-4501. Tzahar E, Yarden Y, et al (1998). The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim. Biophys. Acta 1377: M25-M37. Wang Q, Chen H, Zhou S, et al (2014). Typical laryngeal carcinoid tumor with recurrence and lymph node metastasis: a case report and review of the literature. Int. J. Clin. Exp. Pathol. 7: 9028-9031. Yang AQ, Wang PJ, Huang T, Zhou WL, et al (2016). Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells. Genet. Mol. Res. 15. http://dx.doi.org/10.4238/gmr.15027430 Zhao WM, Xu Y, Wang YM, Cheng ZK, et al (2007). HSV-tk gene delivered by chitosan nanoparticles killed prostate cancer cells in vitro. Tumor 27: 210-213. Zheng L, et al (2013). In vitro response of breast cancer cells (MCF-7) to albumin coated chitosan nanoparticles. China J. Modern Med. 23: 33-36.